Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmoteplase in acute ischaemic stroke
2005-000421-34Phase 3Completed
- Sponsor
- PAION AG
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of desmoteplase in brain infarction (3 arms), sponsored by PAION AG. Primary endpoint: Primary efficacy endpoint. Started Apr 2005; status: completed.
02
Drugs
desmoteplase
03
Conditions
brain infarction
Beyond the preview
Go deeper on 2005-000421-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000421-34.